EverHint – EMA10 × Price × MACD – Top 10 Buy Signals for Apr 14, 2026
10 signals (from 15 total). Healthcare leads (4). 5 with insider selling. 1 with congressional buying. 1 with congressional selling. price range $10-$444. RSI 36-67. sectors: Healthcare (4), Consumer Cyclical (3), Real Estate (2). 1 report earnings within 7 days. full analyst coverage
EverHint Stock Market News — April 6, 2026 (last 12 hours, Evening Update, PT)
Samsung 8x profit surge—AI chips. SpaceX IPO June, huge retail allocation. Oil $110 as Trump deadline looms. Humana +12% Medicare boost. Broadcom/Google AI deal. Tesla slashed on delivery miss. Jefferies: AI capex may peak 2026. Phillips 66 -$900M oil loss. OpenAI vs Musk probe.
EverHint Stock Market News — April 2, 2026 (last 12 hours, Morning Update, PT)
Private credit crisis deepens—Blue Owl gates two funds, 40% redemptions in tech fund. Tesla Q1 deliveries weakest in year, inventory swells. Coinbase wins trust charter. Wall St pares losses on Hormuz reopening hopes. Goldman/Citi Paris staff remote after bomb threat. 100% pharma tariffs coming.
EverHint - Stock Market News — March 20, 2026 — Breaking Developments, Mid-day Update (last 9 hours, Pacific Time)
Super Micro co-founder arrested for chip smuggling to China, shares plunge 27%. European markets log third weekly loss on Mideast war fears. Unilever confirms McCormick food unit sale talks. FedEx surges 7% on resilient demand. UBS secures US banking license.
EverHint - Stock Market News — March 19, 2026 — Evening Update (last 9 hours, Pacific Time)
Natural gas +35% on ME strikes. $FDX raises outlook. Unilever-McCormick talks. $SMCI -14% on arrest. $NVDA 1M $AMZN chips. Tesla $2.9B solar. $BABA weak Q3. Bezos $100B AI fund. Nexstar-Tegna approved. OpenAI superapp.
